FDA sum blood clot risk on birth control pills

<p>WASHINGTON (AP) — Federal health regulators pronounced Tuesday they are adding labeling to Yaz and other newer <span>birth control pills</span> emphasizing that a drugs might be some-more expected to means <span>blood clots</span> than comparison <span>contraceptive pills</span>.</p>
<p>The labeling will request to Bayer’s Yaz, a prototype Yasmin and identical drugs containing a manmade hormone called <span>drospirenone</span>, that mimics a naturally occurring womanlike hormone progesterone. The drugs are among a best-selling contraceptives in a U.S., due to selling emphasizing their ability to transparent adult acne and other hormone-related issues.</p>
<p>The FDA pronounced a new labeling will fact new studies suggesting drospirenone-containing pills lift a somewhat aloft risk of blood clots than other birth control pills. The risk of blood clots with possibly organisation of drugs is still really rare....